A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV
Authors
Keywords
T cells, Cytotoxic T cells, Inflammation, Statins, Antiretrovirals, Blood plasma, Antiretroviral therapy, Cloning
Journal
PLoS One
Volume 15, Issue 9, Pages e0238575
Publisher
Public Library of Science (PLoS)
Online
2020-09-18
DOI
10.1371/journal.pone.0238575
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)
- (2019) Steven K. Grinspoon et al. AMERICAN HEART JOURNAL
- Dynamics of CD4 and CD8 T-Cell Subsets and Inflammatory Biomarkers during Early and Chronic HIV Infection in Mozambican Adults
- (2018) Lucía Pastor et al. Frontiers in Immunology
- Aging in HIV-Infected Subjects: A New Scenario and a New View
- (2017) Eugenia Negredo et al. Biomed Research International
- Effects of randomized rosuvastatin compared with placebo on bone and body composition among HIV-infected adults
- (2015) Kristine M. Erlandson et al. AIDS
- Rosuvastatin Reduces Vascular Inflammation and T-cell and Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy
- (2015) Nicholas T. Funderburg et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir
- (2015) Todd T. Brown et al. JOURNAL OF INFECTIOUS DISEASES
- A population-based study comparing patterns of care delivery on the quality of care for persons living with HIV in Ontario
- (2015) C. E. Kendall et al. BMJ Open
- Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy
- (2014) Laura Galli et al. AIDS
- Impact of darunavir, atazanavir and lopinavir boosted with ritonavir on cultured human endothelial cells: beneficial effect of pravastatin
- (2014) Martine Auclair et al. ANTIVIRAL THERAPY
- Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study
- (2014) J. Schouten et al. CLINICAL INFECTIOUS DISEASES
- Tenofovir/Emtricitabine/Efavirenz Plus Rosuvastatin Decrease Serum Levels of Inflammatory Markers More Than Antiretroviral Drugs Alone in Antiretroviral Therapy-Naive HIV-Infected Patients
- (2014) Leonardo Calza et al. HIV CLINICAL TRIALS
- Will Statins Be an Effective Anti-inflammatory Intervention for Prevention of Cardiovascular Disease in Patients With HIV?
- (2014) M. P. Dube JOURNAL OF INFECTIOUS DISEASES
- Impact of HIV on CD8+ T Cell CD57 Expression Is Distinct from That of CMV and Aging
- (2014) Sulggi A. Lee et al. PLoS One
- Different Plasma Markers of Inflammation Are Influenced by Immune Recovery and cART Composition or Intensification in Treated HIV Infected Individuals
- (2014) Marta Massanella et al. PLoS One
- HIV and aging
- (2014) Peter W. Hunt Current Opinion in HIV and AIDS
- Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection
- (2013) Maria C. Puertas et al. AIDS
- Rosuvastatin Treatment Reduces Markers of Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy
- (2013) N. T. Funderburg et al. CLINICAL INFECTIOUS DISEASES
- Effect of Statin Therapy in Reducing the Risk of Serious Non-AIDS-Defining Events and Nonaccidental Death
- (2013) E. T. Overton et al. CLINICAL INFECTIOUS DISEASES
- Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy
- (2013) Eugènia Negredo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Proinflammatory Cytokines, Aging, and Age-Related Diseases
- (2013) Martin Michaud et al. Journal of the American Medical Directors Association
- Statin Therapy and Mortality in HIV-Infected Individuals; A Danish Nationwide Population-Based Cohort Study
- (2013) Line D. Rasmussen et al. PLoS One
- Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery
- (2012) Marta Massanella et al. AIDS
- Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir
- (2012) Esteban Martínez et al. AIDS
- Statin Therapy Decreases Serum Levels of High-Sensitivity C-Reactive Protein and Tumor Necrosis Factor-α in HIV-Infected Patients Treated With Ritonavir-Boosted Protease Inhibitors
- (2012) Leonardo Calza et al. HIV CLINICAL TRIALS
- HIV and Aging
- (2012) Kevin P. High et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals
- (2012) Daniel A. Duprez et al. PLoS One
- Aging with multimorbidity: A systematic review of the literature
- (2011) Alessandra Marengoni et al. AGEING RESEARCH REVIEWS
- Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study
- (2011) Josep M Llibre et al. ANTIVIRAL THERAPY
- A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal CD4+ T Cell Response
- (2011) Hiroyu Hatano et al. JOURNAL OF INFECTIOUS DISEASES
- Valganciclovir Reduces T Cell Activation in HIV-Infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy
- (2011) Peter W. Hunt et al. JOURNAL OF INFECTIOUS DISEASES
- High Dose Atorvastatin Decreases Cellular Markers of Immune Activation Without Affecting HIV-1 RNA Levels: Results of a Double-blind Randomized Placebo Controlled Clinical Trial
- (2011) Anuradha Ganesan et al. JOURNAL OF INFECTIOUS DISEASES
- Higher Levels of CRP, D-dimer, IL-6, and Hyaluronic Acid Before Initiation of Antiretroviral Therapy (ART) Are Associated With Increased Risk of AIDS or Death
- (2011) David R. Boulware et al. JOURNAL OF INFECTIOUS DISEASES
- T Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in HIV-Infected Women
- (2011) Robert C. Kaplan et al. JOURNAL OF INFECTIOUS DISEASES
- Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
- (2011) Netanya G. Sandler et al. JOURNAL OF INFECTIOUS DISEASES
- Long‐Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment‐Experienced Patients with Drug‐Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials
- (2010) Roy T. Steigbigel et al. CLINICAL INFECTIOUS DISEASES
- Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection
- (2010) Jacqueline Neuhaus et al. JOURNAL OF INFECTIOUS DISEASES
- HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
- (2010) Maria J Buzón et al. NATURE MEDICINE
- Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation
- (2009) N. T. Funderburg et al. BLOOD
- Serum Immune Activation Markers Are Persistently Increased in Patients with HIV Infection after 6 Years of Antiretroviral Therapy despite Suppression of Viral Replication and Reconstitution of CD4+T Cells
- (2009) Martyn A. French et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
- (2009) Jeffrey L Lennox et al. LANCET
- Aging and Infectious Diseases: Workshop on HIV Infection and Aging: What Is Known and Future Research Directions
- (2008) Rita B. Effros et al. CLINICAL INFECTIOUS DISEASES
- Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
- (2008) Lewis H Kuller et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More